XML 47 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2012
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]
A summary of the exit and disposal costs recognized within Loss from Discontinued Operations in the consolidated statements of operations and comprehensive loss for the year ended December 31, 2011 are as follows:

 
For the Year Ended December 31, 2011
Non-cash charges
 
Asset impairments (1)
$
6,913

Cash charges
 

Lease-related charges
392

Severance charges
1,120

Other charges
(12
)
Total charges
$
8,413


(1)
Asset impairments for the year ended December 31, 2011 represent the write-off of Pharmakon's goodwill and other intangible assets.

The major classes of assets and liabilities included in the consolidated balance sheets for Pharmakon and TVG as of December 31, 2012 and December 31, 2011 are as follows:

 
December 31,
 
2012
 
2011
Current assets
$
14

 
$
1,013

Non-current assets
150

 
625

Total assets
$
164

 
$
1,638

Current liabilities
$
368

 
$
1,865

Non-current liabilities
1,006

 
1,526

Total liabilities
$
1,374

 
$
3,391

The table below presents the significant components of Pharmakon's and TVG’s results included in Loss from Discontinued Operations in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2012 and 2011.

 
For the Years Ended December 31,
 
2012
 
2011
Revenue, net
$

 
$
5,880

 
 
 
 
Loss from discontinued operations, before income tax
(51
)
 
(8,374
)
Income tax expense
8

 
(237
)
Loss from discontinued operations, net of tax
$
(59
)
 
$
(8,137
)
A rollforward of the liabilities recognized in the consolidated balance sheet as of December 31, 2012 and December 31, 2011 is as follows: 
Accrued liability as of January 1, 2011
$
16

Add: Costs incurred, excluding non-cash charges
1,120

Less: Cash payments
(16
)
Accrued liability as of December 31, 2011 (1)
$
1,120

Add: Costs incurred, excluding non-cash charges

Less: Cash payments
(1,115
)
Accrued liability as of December 31, 2012 (1)
$
5


(1)
Accrued liability at December 31, 2012 and 2011 consists of Pharmakon employee severance costs.